Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Sorrento Therpt (SRNE)

Sorrento Therpt (SRNE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,528,640
  • Shares Outstanding, K 209,690
  • Annual Sales, $ 31,430 K
  • Annual Income, $ -292,070 K
  • 60-Month Beta 3.17
  • Price/Sales 49.23
  • Price/Cash Flow N/A
  • Price/Book 29.33

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.22
  • Number of Estimates 1
  • High Estimate -0.22
  • Low Estimate -0.22
  • Prior Year -0.39
  • Growth Rate Est. (year over year) +43.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.31 +69.14%
on 06/12/20
7.53 -3.19%
on 07/07/20
+2.57 (+54.45%)
since 06/08/20
3-Month
2.18 +234.40%
on 05/01/20
10.00 -27.10%
on 05/18/20
+4.84 (+197.55%)
since 04/08/20
52-Week
1.39 +424.46%
on 10/11/19
10.00 -27.10%
on 05/18/20
+4.84 (+197.55%)
since 07/08/19

Most Recent Stories

More News
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sorrento Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 27, 2020 - SRNE

New York, New York--(Newsfile Corp. - July 8, 2020) -  The following statement is being issued by Levi & Korsinsky, LLP:

SRNE : 7.29 (-1.22%)
Sorrento Therapeutics (SRNE) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Sorrento Therapeutics (SRNE) closed at $7.29, marking a -1.22% move from the previous day.

SRNE : 7.29 (-1.22%)
Merck Announces Appointment of Organon & Co. General Counsel

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Deborah H. Telman as General Counsel for Organon & Co., its intended spinoff of its women's health,...

SRNE : 7.29 (-1.22%)
MRK : 77.92 (-1.02%)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sorrento Therapeutics, Carnival Corporation, Wells Fargo, and Hebron Technology and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sorrento Therapeutics, Inc. (NASDAQ:...

CCL : 15.32 (+5.15%)
CUK : 12.72 (+5.21%)
SRNE : 7.29 (-1.22%)
WFC : 24.55 (+0.37%)
HEBT : 15.81 (+0.44%)
Has Sorrento Therapeutics (SRNE) Outpaced Other Medical Stocks This Year?

Is (SRNE) Outperforming Other Medical Stocks This Year?

SRNE : 7.29 (-1.22%)
Will Sorrento Therapeutics' Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Sorrento Therapeutics

SRNE : 7.29 (-1.22%)
CLASS ACTION UPDATE for SRNE, CLNY and CCL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / July 8, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested...

SRNE : 7.29 (-1.22%)
CLNY : 2.34 (+2.63%)
CCL : 15.32 (+5.15%)
Sorrento Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Sorrento Therapeutics, Inc. To Contact The Firm

New York, New York--(Newsfile Corp. - July 8, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Sorrento Therapeutics, Inc. ("Sorrento" or the "Company") (NASDAQ:...

SRNE : 7.29 (-1.22%)
Unprecedented Collaboration Formed to Create Vaccine Against COVID-19

, /PRNewswire/ -- The entire global medical community has focused on finding treatments and vaccines to defeat the current global health crisis. Some treatments are showing signs of helping patients survive...

HGRL : 0.0005 (unch)
NNVC : 8.71 (+25.87%)
NVAX : 98.30 (-5.99%)
VXRT : 8.15 (-8.12%)
CRVS : 5.37 (+8.38%)
SRNE : 7.29 (-1.22%)
SRNE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 27, 2020 in the Class Action Filed on Behalf of Sorrento Therapeutics, Inc. Limited Shareholders

New York, New York--(Newsfile Corp. - July 7, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Sorrento Therapeutics, Inc. (NASDAQ: SRNE) alleging...

SRNE : 7.29 (-1.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade SRNE with:

Business Summary

Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and...

See More

Key Turning Points

2nd Resistance Point 7.78
1st Resistance Point 7.54
Last Price 7.29
1st Support Level 7.01
2nd Support Level 6.72

See More

52-Week High 10.00
Last Price 7.29
Fibonacci 61.8% 6.71
Fibonacci 50% 5.70
Fibonacci 38.2% 4.68
52-Week Low 1.39

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar